DNAprint Genomics (DNAG)

[worktoplay]

mingwan0...This company has an interesting history:

http://www.biofrontera.com/company/history.html

history

2004

Biofrontera obtains positive interim report of the adaptive Phase II clinical trial for the treatment of severe chronic urticaria


2003

Biofrontera licenses non-CNS drug discovery projects to BioAgency AG

Biofrontera enters a co-marketing agreement with Evotec OAI AG

1st closing of new VC round, lead by Heidelberg Innovation

Biofrontera acquires the entire operations of bioLeads GmbH, a natural compound company based in Heidelberg/Germany

Biofrontera signs a long-term collaboration with Schering AG (FSE: SCH, NYSE: SHR) to discover and develop new drugs for the treatment of stroke


2002

Biofrontera signs a joint drug discovery and development collaboration with Kiadis BV. The alliance focuses on novel compounds for the treatment of neuropathic pain

Biofrontera opens its integrated platform technology to potential customers

Biofrontera changes into a Holding structure with Biofrontera Pharmaceuticals GmbH as a wholly owned subsidiary


2001

Biofrontera starts own screening programs and announces a collaboration with bioLeads GmbH

Biofrontera enters a 3-year research collaboration with Johnson & Johnson (Janssen Pharmaceutica NV)


2000

Biofrontera Pharmaceuticals GmbH changes into an AG

Biofrontera and Informax begin a strategic alliance for bioinformatics software development

Biofrontera starts research collaborations with leading academic and commercial organisations in the areas of Schizophrenia, Chronic Pain and Stroke

Biofrontera raises 11.8 mln € in a second round of financing

Biofrontera completes its technology platform and starts its first drug discovery collaboration with PharmEco Inc., Lexington, MA, USA


1998

Biofrontera enters a collaboration with Ruhr-University Bochum for the construction of a specified pathogen free (SPF) animal house

Biofrontera Pharmaceuticals starts its operations on February 1st in Leverkusen, Germany. The company raises 10.9 mln € in the largest first round financing in Germany at the time

Later,
W2P